LTF and cancer: The objectives of this study were therefore 1) to prepare and characterize lactoferrin- and lactoferricin-bearing DAB dendrimers and 2) to evaluate their targeting and therapeutic efficacy on cancer cells in vitro and in vivo after intravenous administration.